Hungarian drugmaker Richter reported on Oct. 6 that net profit almost halved in the third quarter from a year earlier, missing market expectations due to rising costs and turmoil in its key Russia and Ukraine markets.
Russia's War Against Ukraine
Hungary’s Richter third quarter net profit almost halves on rising cost
Richter, which makes gynaecological, cardiovascular and central nervous system drugs, missed market forecasts even as quarterly revenue rose by a stronger-than-expected 7.5 percent to 88.8 billion forints.
